Okupe Oluyemi 4

What Happened

• Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), exercised 7,163 stock options and immediately sold the 7,163 shares on July 17, 2026. The exercise cost was $5.01 per share (total $35,887). The shares were sold in the open market at an average weighted price of $31.99 per share for aggregate proceeds of $229,168. The Form 4 also reports the derivative (the option) as disposed in connection with the exercise.

Key Details

• Transaction date: July 17, 2026
• Exercise: 7,163 shares at $5.01 each (total cost $35,887)
• Sale: 7,163 shares at an average $31.99 each (total proceeds $229,168); sale price range reported $31.93–$32.06
• Shares owned after the transaction: not reported on this Form 4
• Notable footnotes:
  • Trades were made pursuant to a pre-established Rule 10b5‑1 trading plan adopted May 21, 2025 (F1).
  • Reported sale price is an average weighted price; filer can provide per‑price breakdown on request (F2).
  • The underlying options have a vesting schedule (25% at 12 months from Jan 24, 2022; remainder monthly over 36 months) (F3).
• Filing timeliness: Form filed July 20, 2026 — within required reporting window (timely).

Context

• This was an option exercise followed by an immediate sale of the acquired shares — effectively a cashless exercise (exercise and concurrent sale), which is common for employees realizing gains on vested options.
• The trade was executed under a 10b5‑1 plan, meaning it was a prearranged program that can reduce the implication that the sale reflects new insider views about the business.